WESPAC Advisors SoCal’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,465
| Closed | -$236K | – | 80 |
|
|
2020
Q4 | $236K | Hold |
2,465
| – | – | 0.09% | 70 |
|
|
2020
Q3 | $257K | Hold |
2,465
| – | – | 0.12% | 64 |
|
|
2020
Q2 | $320K | Hold |
2,465
| – | – | 0.15% | 61 |
|
|
2020
Q1 | $244K | Hold |
2,465
| – | – | 0.14% | 64 |
|
|
2019
Q4 | $265K | Hold |
2,465
| – | – | 0.13% | 72 |
|
|
2019
Q3 | $222K | Hold |
2,465
| – | – | 0.11% | 78 |
|
|
2019
Q2 | $208K | Hold |
2,465
| – | – | 0.11% | 83 |
|
|
2019
Q1 | $217K | Hold |
2,465
| – | – | 0.12% | 85 |
|
|
2018
Q4 | $176K | Hold |
2,465
| – | – | 0.11% | 84 |
|
|
2018
Q3 | $303K | Hold |
2,465
| – | – | 0.15% | 72 |
|
|
2018
Q2 | $242K | Buy |
2,465
+1,800
| +271% | +$177K | 0.14% | 76 |
|
|
2018
Q1 | $55K | Hold |
665
| – | – | 0.03% | 110 |
|
|
2017
Q4 | $51K | Buy |
+665
| New | +$51K | 0.03% | 117 |
|